Get ready for some exciting news from the health and nutrition industry in the Asia-Pacific region! From groundbreaking product launches to strategic acquisitions, here's a round-up of the latest developments that are shaping the market.
The a2 Milk Company's Kids Supplements Debut
The a2 Milk Company is making waves with its entry into the pediatric supplements market in China. With a focus on health and wellness, they're launching four new supplements under the brand a2 Zhi Yi, targeting immunity, anti-allergy, gut health, and brain and eye health. This move is significant as the pediatric supplements market in China is valued at a whopping NZD$8 billion, representing 15-20% of the total supplements market. But here's where it gets controversial... some experts argue that the market is already saturated, and the company will need to find a unique selling point to stand out.
POCARI SWEAT's New Factory
Otsuka Pharmaceutical Co. Ltd, the owner of the popular electrolyte drink POCARI SWEAT, is expanding its production in China. With the opening of a new factory in Tianjin, they aim to produce 300 million 500 ml bottles annually. This move is in response to the rising demand for hydration and electrolyte beverages in Northern China. But this development also raises questions about the sustainability of such expansion, as it may impact the environment and local communities.
Hindustan Unilever's Acquisition of OZiva
Hindustan Unilever is making a significant move by fully acquiring the clean-label protein and women's health supplements firm OZiva for INR 8.24 billion (US$90.9 million). This acquisition will make OZiva, also known as Zywie Ventures Private Limited, a wholly-owned subsidiary of Hindustan Unilever (HUL). However, this move has sparked debates about the future of the company's other brands, as HUL plans to sell its stakes in Nutritionalab Private Limited, the company behind the Wellbeing Nutrition brand.
Blackmores CEO Leading New Entity
Alastair Symington, CEO of Blackmores Limited, is taking on a new role as the head of a new entity set up by parent company Kirin Holdings Company. The new entity, named Kirin Health Science International (KHSI) Pty Ltd, will oversee Kirin's B2C health science businesses outside Japan. This move is seen as a strategic step to expand the company's reach in the global health and wellness market.
Bayer's Investment in Indonesia
Bayer is pouring €5 million (US$5.9 million) into its multiple micronutrient supplement production line and R&D center in Indonesia. Part of this investment went to upgrading the company's production site, introducing digitalization and automation to optimize production output by around 20%. This move is seen as a strategic step to expand the company's presence in the Indonesian market and strengthen its position in the global health and nutrition industry.
These developments are just the tip of the iceberg, and there's much more to explore in the health and nutrition industry. Stay tuned for more updates and insights as we continue to bring you the latest news and trends from the Asia-Pacific region.
